SCHEMBL6738103

SCHEMBL6738103

CC(C)(S)[C@@H](N)C(=O)NCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
PTGS1 P23219 1/20 0.48
ECE1 P42892 4/20 0.46
ACE P12821 2/20 0.39
MME P08473 1/20 0.39
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRE P78334 2/20 0.35
GABRA6 Q16445 2/20 0.35
GABRG1 Q8N1C3 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6739306 0.98 ALDH1A1 (0.47) ALDH1A1MAPTPTGS1ECE1ACE
SCHEMBL6734271 0.81 ALDH1A1 (0.52) ALDH1A1MAPTPTGS1ECE1ACE
SCHEMBL18629893 0.81 PTGS1 (0.47) ALDH1A1MAPTPTGS1
SCHEMBL7756796 0.81 ALDH1A1 (0.52) ALDH1A1MAPTPTGS1ECE1ACE
Hydrochloric Acid SCHEMBL7753276 0.80 ALDH1A1 (0.50) ALDH1A1MAPTPTGS1ECE1ACE
Hydrochloric Acid SCHEMBL6741437 0.80 ALDH1A1 (0.50) ALDH1A1MAPTPTGS1ECE1ACE
SCHEMBL14755648 0.80 PTGS1 (0.45) ALDH1A1MAPTPTGS1
SCHEMBL14752342 0.79 ANPEP (0.51) ALDH1A1MAPTPTGS1
SCHEMBL12908822 0.77 ALDH1A1 (0.50) ALDH1A1MAPTPTGS1
SCHEMBL9330023 0.75 ADRA1A (0.43) PTGS1ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686336-B2 ALCOHOLISM THERAPY FEDERAL GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRES 2004-02-03 US claimed
US-6686336-B2 ALCOHOLISM THERAPY FEDERAL GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRES 2004-02-03 US disclosed
US-20010041789-A1 N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents FEDERAL GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2001-11-15 US disclosed
WO-2001058928-A1 N-TERMINAL D(-)-PENICILLAMINE PEPTIDES AS ALDEHYDE SEQUESTRATION AGENTS NAGASAWA HERBERT T (US) 2001-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010041789-A1 N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents ADH1C, ADH1A, ADH5 ALDH1A1 4/4885MAPT 2369/4885PTGS1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.